The C2N team discovers and advances unique therapeutic molecules by applying its understanding of biological mediators of neurodegeneration. We use scientific discipline, creativity, efficiency, and external collaboration to bring to the clinic biopharmaceutical products that have potential to change the course of unmet medical needs.